303 related articles for article (PubMed ID: 26275479)
21. [Long effect of a booster on rubella antibodies from each original HI titer following vaccination].
Terada K; Akaike H; Ogita S; Ouchi K
Kansenshogaku Zasshi; 2014 Jan; 88(1):110-6. PubMed ID: 24665587
[TBL] [Abstract][Full Text] [Related]
22. Psychological variables as predictors of rubella antibody titers and fatigue--a prospective, double blind study.
Morag M; Morag A; Reichenberg A; Lerer B; Yirmiya R
J Psychiatr Res; 1999; 33(5):389-95. PubMed ID: 10504007
[TBL] [Abstract][Full Text] [Related]
23. Postinfection and postvaccination antirubella immunity.
Kańtoch M; Imbs D
Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
[TBL] [Abstract][Full Text] [Related]
24. [Antibody response to live rubella vaccination and its clinical meanings].
Hoshiba T; Yabuki Y; Asamoto A; Kimura N; Tanaka J
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2029-35. PubMed ID: 3429985
[TBL] [Abstract][Full Text] [Related]
25. [Phases 3 and 4 immunization immunogenicity with combined measles-rubella vaccine].
Ozaki T; Nishimura N; Gotoh K; Ohe K; Funahashi K; Maeda K; Okuno Y
Kansenshogaku Zasshi; 2011 May; 85(3):250-5. PubMed ID: 21706844
[TBL] [Abstract][Full Text] [Related]
26. Persistence of Immunity Acquired after a Single Dose of Rubella Vaccine in Japan.
Okafuji T; Okafuji T; Nakayama T
Jpn J Infect Dis; 2016 May; 69(3):221-3. PubMed ID: 26255735
[TBL] [Abstract][Full Text] [Related]
27. Serological assessment of measles-rubella vaccination catch-up campaign among university students.
Takeuchi J; Goto M; Kawamura T; Hiraide A
Pediatr Int; 2014 Jun; 56(3):395-9. PubMed ID: 24417932
[TBL] [Abstract][Full Text] [Related]
28. [Preliminary study on nasal spray of interferon alpha-2b used for prevention of rubella and measles virus infections].
Zhao J; Zhu FC; Shu YL; Zhou R; Liu LQ; Zhang LL; Shi ZY; Tang Z; Lin LZ; Yu ZA; Zhang LP; Zhang B; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):220-2. PubMed ID: 16261201
[TBL] [Abstract][Full Text] [Related]
29. Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity.
Tosh PK; Kennedy RB; Vierkant RA; Jacobson RM; Poland GA
Viral Immunol; 2009 Dec; 22(6):451-6. PubMed ID: 19951182
[TBL] [Abstract][Full Text] [Related]
30. Serological response to rubella revaccination.
Serdula MK; Halstead SB; Wiebenga NH; Herrmann KL
JAMA; 1984 Apr; 251(15):1974-7. PubMed ID: 6700099
[TBL] [Abstract][Full Text] [Related]
31. [Immune status of a school-population sample 5 years after antirubella vaccination].
Quaglio P; Dattoli A; Mantovani G
G Batteriol Virol Immunol; 1982; 75(7-12):233-8. PubMed ID: 7188256
[TBL] [Abstract][Full Text] [Related]
32. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
Peetermans J; du Pan RM; Huygelen C
Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
[TBL] [Abstract][Full Text] [Related]
33. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
Schluederberg A; Horstmann DM; Andiman WA; Randolph MF
J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058
[TBL] [Abstract][Full Text] [Related]
34. Impaired cellular immunity to rubella virus in congenital rubella.
Fuccillo DA; Steele RW; Hensen SA; Vincent MM; Hardy JB; Bellanti JA
Infect Immun; 1974 Jan; 9(1):81-4. PubMed ID: 4808855
[TBL] [Abstract][Full Text] [Related]
35. Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.
Mitchell LA; Ho MK; Rogers JE; Tingle AJ; Marusyk RG; Weber JM; Duclos P; Tepper ML; Lacroix M; Zrein M
J Clin Microbiol; 1996 Sep; 34(9):2210-8. PubMed ID: 8862587
[TBL] [Abstract][Full Text] [Related]
36. The status of rubella immunity among pregnant women in Kuwait: screening in childbearing age should be reintroduced.
Makhseed M; Moussa MA; Ahmed MA; Abdulla N
Acta Trop; 2001 Jan; 78(1):35-40. PubMed ID: 11164749
[TBL] [Abstract][Full Text] [Related]
37. Determination of rubella virus-specific cell-mediated immunity using IFN gamma-ELISpot.
Allmendinger J; Paradies F; Kamprad M; Richter T; Pustowoit B; Liebert UG
J Med Virol; 2010 Feb; 82(2):335-40. PubMed ID: 20029797
[TBL] [Abstract][Full Text] [Related]
38. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
Just M; Just V; Berger R; Burkhardt F; Schilt U
Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
[TBL] [Abstract][Full Text] [Related]
39. Rubella antibody titer. The significance of low-titered rubella antibodies.
Harris RE; Jordon PA; Monif GR
Obstet Gynecol; 1978 Aug; 52(2):243-5. PubMed ID: 683666
[TBL] [Abstract][Full Text] [Related]
40. Rubella antibody titres and immunization status in a family practice.
Mills DA; Parker KR; Evans CE
Can Med Assoc J; 1980 Mar; 122(5):549-52. PubMed ID: 7370858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
